分类: health

  • Ebola outbreak in DR Congo becomes deadliest in its history

    Ebola outbreak in DR Congo becomes deadliest in its history

    The Democratic Republic of the Congo (DRC) is currently facing the most devastating Ebola outbreak in the nation’s recorded history, public health authorities have confirmed. As of mid-August 2026, the death toll from the outbreak, first declared on 15 May, has reached 2,325, surpassing the fatalities recorded during the country’s 2018–2020 Ebola epidemic to claim the grim title of the deadliest outbreak in DRC history.

    Just one week ahead of the new death toll announcement, United Nations Under-Secretary-General for Humanitarian Affairs Tom Fletcher described the current outbreak as the fastest-spreading on record. In a stark warning, Fletcher noted that the virus is claiming a human life every 30 minutes on average.

    On 4 August, authorities inaugurated a new Ebola treatment facility in Rwakole, located in the Bunia region of northeastern DRC, to help expand care capacity amid the surging crisis. As of the latest update from the DRC Institute of Public Health released on 10 August, the country has confirmed 4,945 total cases of the virus, with 101 new positive cases recorded in the 24 hours prior to the announcement.

    Unlike previous Ebola outbreaks that have impacted the DRC, the current epidemic is driven by the rare Bundibugyo strain of the virus, for which no globally approved vaccine currently exists. That said, multiple vaccine candidates are already in active development, including one candidate built on the same viral vector technology that powered the Oxford-AstraZeneca COVID-19 vaccine. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has already granted regulatory approval for the first human clinical trials of this Oxford University-developed candidate, with three additional research groups also working on separate Bundibugyo vaccine candidates. The World Health Organization (WHO) is also sponsoring an independent clinical trial based in the DRC to test whether two existing antiviral therapies can improve survival rates for patients infected with the virus.

    Transmission of the virus has outpaced all recent precedents, the WHO has confirmed, noting the spread of the pathogen to six of the DRC’s 26 provinces is moving at an “exceptional” pace. To contextualize the speed: the 2014–2016 West African Ebola outbreak, the deadliest globally in recorded history, took nearly five months to reach 1,000 fatalities. The current DRC outbreak surpassed 2,000 deaths in less than three months since it was declared.

    So far, cross-border spread has been limited. As of 12 August, only 20 confirmed cases have been detected in neighboring Uganda, two patients have received treatment in Germany, and a single case has been reported in France.

    This current outbreak marks the 17th Ebola event the DRC has responded to since the virus was first identified half a century ago. Long-standing systemic challenges, including years of armed conflict in affected regions and a highly mobile population, have compounded the country’s ability to control transmission and slow the outbreak.

    Ebola is a highly lethal viral pathogen that spreads through direct contact with infected bodily fluids such as blood or vomit. Initial symptoms, which develop between two and 21 days after infection, are easily mistaken for more common illnesses like malaria or influenza, including sudden onset fever, headache, and fatigue. As the infection progresses, patients often develop severe vomiting and diarrhea that can lead to acute organ failure and death. The Bundibugyo strain responsible for the current outbreak is particularly rare, with only two documented prior outbreaks recorded globally.

    The WHO has outlined an ambitious target to reverse the trend of transmission within three months, though the organization clarifies that this goal focuses on bringing community spread under control, not fully eradicating the outbreak entirely at this stage.

  • Exhausted health workers in Congo struggle to keep up as Ebola outpaces contact tracing

    Exhausted health workers in Congo struggle to keep up as Ebola outpaces contact tracing

    In the conflict-wracked eastern Democratic Republic of the Congo, community health teams led by workers like Gédéon Banga Ngbape wage a daily uphill battle to contain the country’s fastest-growing Ebola outbreak on record. Every dawn, Ngbape and his surveillance crew spread across communities in Nizi, one of the outbreak’s hardest-hit health zones in Ituri province, chasing down alerts of suspected cases, tracking contacts of infected people, and rushing symptomatic residents to care before the virus can jump to new hosts. But this critical frontline work is being undermined by gaps that have left responders racing to catch up to a virus that is already outpacing their efforts.

    Latest government data confirms the scale of the crisis: more than 4,700 confirmed cases have been recorded, with over 2,200 deaths. This death toll was accumulated nearly three times faster than the 2014-2016 West African Ebola epidemic, the previous deadliest on record which killed more than 11,000 people over two years. “We are chasing the virus; the virus is ahead of us,” Dr. Mohamed Yakub Janabi, World Health Organization Regional Director for Africa, acknowledged this week, echoing a widespread sentiment among responders.

    The most critical flaw in the response lies in the broken surveillance system, the backbone of any successful outbreak containment. Between 60 and 70 percent of new infections are now being detected in people who were never flagged as close contacts of confirmed cases, meaning health workers only identify infections after patients have already circulated in communities and exposed others to the virus. “If surveillance does not work well, the entire response suffers,” Ngbape said. “Surveillance is the engine of a response.”

    Frontline workers bear the brunt of these systemic failures, working grueling hours for little pay and lacking even basic protective supplies. Ngbape’s team handles an average of 60 to 70 alerts daily, with shifts that often stretch from 8 a.m. to midnight, followed by additional planning for the next day’s work. “I feel really tired, but what matters to me is always being of service to the community,” Ngbape said.

    Community health worker Ana Ndroy Kasime, who conducts door-to-door education and case reporting in Nizi, says teams lack essential protective gear including boots and hospital-grade disinfectant, forcing workers to purchase supplies out of their own meager salaries. Kasime, who earns roughly $50 per month for her high-risk work, calls the compensation totally inadequate for the demands of the job.

    Widespread labor unrest has further crippled response efforts. On Thursday, health workers at the Nizi Treatment Center launched a strike and temporarily shut down the facility after going more than three months without pay. Jean Kaseya, head of the Africa Centers for Disease Control and Prevention, called on the Congolese government to immediately disburse back wages, noting funding is already available and paying frontline workers is a core government responsibility. The government has defended the delays, saying it is cleaning up payrolls that were inflated with fake names and transitioning from cash payments to digital mobile money transfers. While community health workers like Kasime have received their salaries, she warns that delayed pay for other response staff puts the entire outbreak response at risk. “They are making sacrifices and taking risks,” she said. “If these workers decide to stop working, the epidemic will spread further into the population.”

    Compounding these challenges is the unique danger posed by the current strain of the virus: this outbreak is caused by the rare Bundibugyo Ebola variant, for which no approved vaccines or specific treatments exist, though clinical trials are currently underway. Eastern Congo’s long-running instability also creates insurmountable barriers to contact tracing: dozens of rebel and militia groups, including the Islamic State-linked Allied Democratic Forces, operate across Ituri province, forcing many aid and health workers to flee remote outbreak hotspots for the relative safety of the provincial capital Bunia. As of mid-July, local health authorities have recorded at least a dozen attacks on health facilities and response workers, fueled in part by widespread misinformation claiming Ebola does not exist and anger over public health bans on traditional funeral gatherings, a known driver of Ebola transmission.

    Frequent population movement, driven by artisanal mining and people fleeing conflict, also makes it nearly impossible for teams to track exposed contacts before they develop symptoms. Many remote areas are cut off by poorly maintained or impassable roads, and insecurity restricts where responders can safely travel, leaving entire communities without any surveillance coverage. Ngbape notes that cooperation from local residents in Nizi has improved in recent weeks as communities have become more familiar with his team’s work, and widespread concealment of cases is not a major issue in the area. Still, population movement and limited transportation leave many contacts unaccounted for.

    Despite exhaustion from endless long hours and constant resource shortages, Ngbape says he has no intention of stepping back. Maintaining surveillance, he argues, is the only way to stop small clusters of infection from growing into large, uncontrolled community transmission. For him, the mission remains clear: “I am here to save the lives of the population.”

    In a small bright spot for the response, United Nations humanitarian chief Tom Fletcher announced Friday an additional $30.5 million in emergency funding to scale up Ebola response efforts in the country. The outbreak has already spread to six of Congo’s provinces, according to recent official reports. This reporting was supported by a grant from the Gates Foundation to the Associated Press for global health and development coverage in Africa, with the AP retaining full editorial control over all content.

  • Myanmar faces rise in diarrhea as monsoon flooding continue to worsen in many parts of the country

    Myanmar faces rise in diarrhea as monsoon flooding continue to worsen in many parts of the country

    BANGKOK – Myanmar’s most populous urban center, Yangon, is facing a worrying spike in acute diarrhea cases that has compounded the cascading crises facing the conflict-wracked nation already reeling from widespread severe flooding and years of civil unrest, state media confirmed Friday.

    State-run publication Myanma Alinn reported that over the four-day period ending Friday, 182 diarrhea patients were admitted to Yangon General Hospital, with 93 of those patients testing positive for pathogens known to cause the gastrointestinal illness. The official report did not name the specific pathogens detected, nor did it confirm whether any cases were cholera, a highly contagious waterborne disease that can turn fatal if left untreated.

    However, local independent Myanmar news outlet Eleven Media previously reported Wednesday, citing Aye Mya Thae Phyu, a lawmaker representing Yangon’s Latha township, that the positive test results were confirmed to be cholera. On Thursday, the military government’s information team also confirmed to reporters that one 92-year-old patient has died from the disease.

    In comments published by the state newspaper, Aung Lin Aye, deputy medical superintendent of Yangon General Hospital, acknowledged that case numbers have climbed sharply in recent days. The hospital has reallocated resources to prioritize life-saving treatment and prevent additional fatalities, he added.

    According to the report, Nanda Win, director of the Yangon Regional Department of Public Health, noted that most cases are concentrated in Yangon’s downtown Chinatown district, a dense hub packed with street food vendors, restaurants, and bars. Unsafe takeaway food from street vendors and contaminated drinking water used by these small businesses are the most likely sources of the outbreak, Nanda Win said, while adding that new case numbers have started to trend downward in recent days.

    Another state-owned publication, *Global New Light of Myanmar*, reported that public health authorities have ordered street food vendors selling high-risk items to suspend operations for three days to slow the spread of the pathogen. Three Chinatown food and beverage establishments confirmed the mandatory three-day closure to the Associated Press in on-the-record interviews.

    Acute gastrointestinal outbreaks are a recurring annual threat for Yangon during the monsoon season, when heavy rains often contaminate local water supplies. World Health Organization data shows that in 2024 alone, more than 2,200 people were hospitalized with acute watery diarrhea in Yangon, resulting in 15 recorded deaths.

    This latest public health emergency emerges as widespread monsoon flooding continues to displace communities across large swathes of Myanmar, adding another layer of hardship to a population already exhausted by more than three years of armed conflict. The conflict erupted in 2021, when the military seized power in a coup that ousted the elected civilian government led by Aung San Suu Kyi, triggering a nationwide civil war that has crippled the country’s healthcare system and economy.

  • Thousands of Australians to receive official government letter on dementia risk in new prevention push

    Thousands of Australians to receive official government letter on dementia risk in new prevention push

    In a landmark public health initiative targeting one of Australia’s fastest growing chronic neurological conditions, the federal government is set to mail personalized dementia risk awareness letters to nearly 350,000 Australians turning 50 over the coming 12 months, backed by leading dementia researchers and aged care officials calling for urgent national action on prevention.

    Starting July 1, the outreach campaign will reach all citizens hitting the 50-year milestone between July 2025 and June 2026. Crafted in consultation with leading dementia clinical and research experts, the letters outline evidence-based steps people can take to cut their dementia risk, from reducing alcohol consumption and adopting nutrient-dense eating patterns to quitting tobacco use. Recipients are also encouraged to schedule regular screenings for cardiovascular disease and diabetes, two conditions linked to elevated dementia risk, and to prioritize ongoing cognitive stimulation through lifelong learning and mentally engaging activities. To help people understand their individual risk profile, all recipients will also gain access to a complimentary personalized dementia risk assessment.

    The campaign comes as 2026 Senior Australian of the Year Professor Henry Brodaty AO, a world-leading dementia researcher, throws his weight behind national prevention efforts, drawing a parallel to Australia’s successful public health campaigns that cut rates of skin cancer, smoking-related illness and heart attack deaths. “We are now ready to tackle dementia prevention,” Brodaty said. “Many trials internationally, including our own Maintain Your Brain trial, have shown that addressing modifiable risk factors for dementia can improve cognitive abilities and delay cognitive decline. Let’s do the ‘Slip, Slop, Slap’ of brain health” — a reference to Australia’s iconic sun safety campaign that became a model for public health outreach globally.

    Current data paints a stark picture of dementia’s growing impact on Australia’s aging population: around 469,000 Australians are currently living with the condition, and that number is projected to surge to more than 1.1 million by 2058 as life expectancies rise and population aging accelerates. However, peer-reviewed research consistently shows that as much as 45 percent of all dementia cases could be delayed entirely, or prevented outright, by addressing known modifiable risk factors — a statistic that has underscored the urgency of the government’s new midlife outreach campaign.

    Aged Care Minister Sam Rae explained that the initiative is designed to be more than just a warning: it is intended to spark critical conversations about brain health that many people delay until it is too late. “These letters are a simple prompt to start a conversation every Australian should be having with loved ones and their doctor,” Rae said. “The science is clear that the choices we make in midlife matter. Staying active, eating well and keeping on top of your heart health can help reduce your risk of developing dementia. Together we can bring dementia numbers down and give more older Australians longer, healthier lives.”

    Dementia Australia chief executive Professor Tanya Buchanan echoed that sentiment, emphasizing that it is never too early or too late to prioritize brain health. “While we cannot change getting older, our genetics or family history, scientific research shows that looking after our brain health can make a big difference to reducing the risk of developing dementia,” Buchanan said. She also noted that many lesser-known modifiable risk factors often surprise the public: addressing hearing and vision loss, treating clinical depression, and maintaining consistent social connection all contribute to lower dementia risk. “Making sure there are services and support to help people address risk factors is vitally important,” she added.

    The national letter campaign aligns with a string of recent advancements in dementia care in Australia, including the recent launch of the nation’s first locally accessible Alzheimer’s blood test, a breakthrough tool that enables far earlier detection of the disease than traditional diagnostic methods.

  • Two children admitted to hospital after contracting bacterial infection from Melbourne petting zoo

    Two children admitted to hospital after contracting bacterial infection from Melbourne petting zoo

    An ongoing investigation by Victoria’s Department of Health has been launched after an outbreak of shiga toxin-producing Escherichia coli (STEC), a dangerous foodborne and zoonotic bacterial pathogen, linked to a Melbourne petting zoo left two young children hospitalized, with one facing lifelong health impacts and a potential kidney transplant.

    Four weeks ago, a 3-year-old child was admitted to Monash Children’s Hospital following infection contracted during a visit to the interactive animal attraction. The toddler has already developed permanent brain damage and acute kidney failure, with clinical teams indicating a kidney transplant may be necessary to sustain long-term health. A second infected child, aged 2, spent more than two weeks receiving life-sustaining dialysis at the same hospital unit after falling ill from the same outbreak.

    According to Australia’s Centre for Disease Control (CDC), STEC bacteria naturally reside in the gastrointestinal tract and faeces of many animals, with cattle being the most common carrier. The agency records more than 1,000 confirmed STEC infections across the country annually, and the pathogen can trigger severe gastrointestinal distress and catastrophic kidney dysfunction in vulnerable populations. In the most serious cases, STEC infection progresses to haemolytic uraemic syndrome (HUS), a life-threatening condition that destroys red blood cells and causes irreversible kidney damage. Both STEC infection and HUS disproportionately affect children under five years old, and no vaccine currently exists to prevent infection.

    Typical symptoms of STEC infection, including watery or bloody diarrhoea, abdominal cramping, nausea, and vomiting, develop three to four days after initial exposure. Infected children can carry and spread the bacteria for up to three weeks, while adults typically remain contagious for approximately one week. The CDC confirms that direct contact with animals at petting zoos and farms is a well-documented transmission route, but infection can also occur through swallowing contaminated recreational water, or consuming contaminated food or beverages.

    Victoria’s Chief Health Officer Caroline McElnay has issued a public warning urging parents and caregivers to prioritize rigorous hand hygiene to reduce infection risk. “Good hand hygiene is one of the most effective ways to protect yourself and your family from infections that can, in rare cases, lead to serious illness such as haemolytic uraemic syndrome,” McElnay stated. “While HUS is very rare, young children can become seriously unwell, so it’s important to wash your hands, and help children wash theirs, after using the toilet and after contact with animals.”

    The Department of Health’s investigation into the source and scope of the outbreak remains ongoing as of press time.

  • New trend of injecting banned peptides to ‘optimise’ body

    New trend of injecting banned peptides to ‘optimise’ body

    A growing global trend of unregulated, banned peptide injection among fitness enthusiasts and aspiring bodybuilders is raising urgent red flags from medical and scientific experts, who warn the untested practice carries severe, underreported health risks.

    For 29-year-old aspiring bodybuilder Thomas (a pseudonym to protect his identity), based in France where the substances he uses are outlawed, injecting peptides has become a fixed part of his daily routine. Every evening at 9:30 p.m., his phone alarm reminds him to mix and self-administer two banned synthetic peptides into his lower abdomen: daily doses of GHK-Cu, which he says improves skin quality, and Retatrutide, taken three times weekly to curb appetite. Six months after first trying peptides while already using steroids, Thomas has added two more unapproved substances to his regimen: Selank to ease anxiety, and BPC-157, marketed to speed up soft tissue and ligament repair after gym workouts.

    Since France bans the sale and use of these peptides, no official dosage guidelines or safety protocols exist. Like hundreds of other mostly male users, Thomas gets his advice from anonymous online communities on Reddit and Discord, where users swap anecdotes about dosing and claimed benefits. “It takes a little organisation, but it’s become a routine,” Thomas told Agence France-Presse, adding he dismisses warnings of risk, which he calls “rare and not serious.”

    Thomas is far from alone. Driven by viral social media content from influencers, celebrities and the unregulated wellness industry, peptides are being widely marketed as a miracle solution for everything from anti-aging and clearer skin to muscle growth, improved sleep and sharper cognitive function. The narrative of “biological optimization” pushed online frames the human body as a form of capital that can be upgraded with chemical supplements, attracting growing numbers of people willing to self-experiment with untested substances.

    Peptides themselves are not inherently dangerous: short chains of amino acids that form proteins, they occur naturally in the human body and regulate critical processes like tissue repair. Lab-synthesized peptides are also approved as active ingredients in many common medications, including insulin and popular GLP-1 weight loss drugs. But the unregulated, unauthorized versions sold via gym networks and online marketplaces have never undergone rigorous clinical testing to confirm their claimed benefits or safety.

    French national research institute INSERM stresses that no large-scale, randomized controlled human trial has ever validated the sweeping benefits marketed for unapproved peptides. Neuroscientist Armelle Rancillac of INSERM noted most of these compounds have never even been tested on human subjects, leaving even experienced users with no accurate understanding of correct dosing or long-term side effects. Claims from online self-experimenters, she argued, are scientifically worthless and are given far too much credibility by audiences eager for quick physical results.

    The warnings are backed by documented hospitalizations linked to unregulated peptide use. Earlier this year, Australian health authorities confirmed six cases of acute liver injury directly tied to Retatrutide-containing products. While exact data on how many people use unapproved peptides is hard to collect, Swiss University of Lausanne sports sociologist Fabien Ohl told AFP the sharp rise in exposure alone is enough to “raise alarm.”

    Ohl also criticized the harmful ideological underpinning of the trend: the online framing of masculinity that ties male worth to physical optimization via chemical enhancement, which he says normalizes a dangerous ideal of “the biological male who is potentially more violent and aggressive.”

    The regulatory landscape around peptides remains fractured. Many countries, including France, ban unapproved synthetic peptides entirely due to safety concerns, but the issue has become contentious in the United States. Last month, a federal advisory panel made a controversial recommendation to loosen restrictions on a range of unapproved peptides. The decision drew fierce backlash from the medical community, which accuses US Health Secretary Robert F. Kennedy Jr. — an avowed public user and fan of peptides — of stacking the panel with industry-linked allies to push for deregulation.

  • Congo’s fastest-growing Ebola outbreak reaches a sixth province

    Congo’s fastest-growing Ebola outbreak reaches a sixth province

    KINSHASA, Democratic Republic of Congo – The ongoing deadly Ebola outbreak in eastern Democratic Republic of Congo has expanded into a sixth previously unaffected province, with the first fatality recorded in Bas-Uele, Africa Centres for Disease Control and Prevention Director-General Jean Kaseya confirmed Thursday.

    The deceased patient, Kaseya explained, had traveled from Isiro, a community in the already impacted Haut-Uele province, to Buta – the capital city of Bas-Uele – before succumbing to the virus.

    The World Health Organization warned Wednesday that this current outbreak, driven by the rare Bundibugyo strain of Ebola, is already the fastest-growing event of its kind on record and is on course to surpass the 2013-2016 West African outbreak, the deadliest Ebola event in history that claimed more than 11,000 lives. Unlike outbreaks of more common Ebola strains, there are currently no formally approved vaccines or targeted treatments available for the Bundibugyo variant driving the current surge.

    Latest official data from the Congolese government puts the outbreak’s cumulative case count above 4,500, with more than 2,100 deaths recorded to date. Alarmingly, this death toll has been reached nearly three times faster than the same mortality milestone during the 2014-2016 West African outbreak, signaling an unprecedented rate of spread.

    Response efforts are being severely hampered by a perfect storm of systemic and security challenges. Unpaid health workers have launched widespread strikes, armed rebel groups operate in many affected regions, deep-seated distrust among long-traumatized local communities undermines containment work, and pervasive misinformation claiming Ebola does not exist has discouraged participation in public health measures. These barriers have allowed the virus to outpace intervention teams across the country.

    On the same day the expansion to Bas-Uele was announced, health workers at the Nizi Treatment Center in Ituri – the hardest-hit province in the outbreak – walked off the job, forcing the facility to temporarily close. Workers reported they had not received any salary for three months, a grievance that has disrupted care across multiple response sites.

    Compounding the crisis, the true scale of the outbreak remains undercounted and poorly understood. Though the outbreak was formally declared on May 15, recent genetic sequencing conducted by the WHO confirms the virus was circulating as early as February, months before official detection. Health authorities estimate that 60 to 70 percent of new confirmed cases are found among community members not already on monitored contact lists, confirming the virus is spreading widely through undetected community transmission.

    “We are chasing the virus; the virus is ahead of us,” Dr. Mohamed Yakub Janabi, the WHO Regional Director for Africa, stated this week, summarizing the growing gap between spread and response.

    Ebola is a rare but highly contagious viral pathogen that spreads through direct contact with infected bodily fluids including blood, vomit and semen, as well as exposure to contaminated surfaces and materials like bedding and clothing. Infection causes severe acute illness that carries a high risk of fatality without targeted care.

    In a small bright spot for the response, clinical trials for two potential treatments specific to this strain of Ebola launched last month in Ituri, offering hope that targeted medical options could become available in the coming months.

  • USAID fallout: In Nepal, when the aid workers stopped coming, the women and babies started dying

    USAID fallout: In Nepal, when the aid workers stopped coming, the women and babies started dying

    In the parched, poverty-stricken villages of Nepal’s Rautahat district, a preventable tragedy unfolded in late 2025 that encapsulates the global human cost of sweeping U.S. foreign aid cuts. Twenty-year-old Kabita Mukhiya, a young mother of three who dreamed of giving her unborn son the education she never had, suffered for weeks from unexplained abdominal agony and swelling during her 28-week pregnancy. Uneducated, impoverished, and abandoned by the community outreach workers who once monitored at-risk pregnant women in her village, Kabita did not know she was experiencing life-threatening complications. When her aunt finally carried her to a hospital, it was too late: her unborn baby was dead, and Kabita herself died hours later from untreated eclampsia and severe anemia, conditions that routine prenatal care could have detected and managed.

    Kabita’s death is not an isolated incident. It is one of hundreds of preventable maternal and child fatalities documented by the Associated Press across the globe following the Trump administration’s decision to dissolve the United States Agency for International Development (USAID), for decades the world’s largest single provider of humanitarian assistance. The U.S. funding cuts, which shuttered life-saving maternal and neonatal health programs, eliminated nutritional support for pregnant people and young children, and idled thousands of community outreach workers, have been followed by additional aid reductions from other donor nations. The World Health Organization (WHO) estimates that 60% of women’s health organizations globally have been forced to slash critical services as a result.

    Global public health experts are already bracing for a devastating turning point. The Bill & Melinda Gates Foundation projects that 2025 will be the first year of this century to see an increase in global child mortality, reversing decades of steady progress in reducing preventable deaths. A study published in *The Lancet* warns that the U.S. aid cuts could lead to more than 14 million excess deaths by 2030, including over 4.5 million deaths of children under age 5. WHO’s Rajat Khosla, executive director of the Partnership for Maternal, Newborn and Child Health, calls the reversal catastrophic: “It’s heartbreaking to see what’s happening. It’s decades of progress being washed away.”

    In response to AP’s reporting, the U.S. State Department defended the administration’s policy, stating that the restructuring refocuses assistance on efficiency, effectiveness, and global partnership. The department noted that the U.S. still spends more on health and humanitarian aid than any other nation, and continues to support maternal and child health programs in Nepal, adding that “the rest of the world needs to contribute more and share the burden.”

    On the ground in Nepal, however, local health workers and aid organizations say the impact of the cuts has already been catastrophic. CARE Nepal, one of the largest aid groups operating in the country, lost more than half of its funding from the U.S. cuts. “The number of deaths of mothers, young mothers, during delivery has really increased,” said Mona Sherpa, CARE Nepal’s country director. “The expected number within a year is happening within four to six months.”

    Prior to the cuts, USAID funded a five-year, $35 million maternal and child health initiative in Nepal that reached more than 100,000 women and girls in its first three years. The program equipped rural birthing centers with life-saving equipment and medications, trained nurses and midwives, and supported a network of female community health volunteers who made regular home visits to pregnant women. These volunteers identified warning signs of complications, helped women schedule and access prenatal appointments, and explained critical medical information in terms local communities could understand.

    When the program was shut down, the volunteer network collapsed. In Dewahi Gonahi municipality, the head of the local birthing center, Kishori Shah, reports that the number of women attending prenatal checks has dropped by 50% since the cuts. Without early screening, complications that could be easily managed are left to escalate into life-threatening emergencies. “There would have been a decrease in complications if the USAID program was still running,” Shah says.

    In Prempur Gonahi village, the reversal of progress is stark. Before the program launched in 2022, the village saw an average of 10 to 15 neonatal deaths per year. By 2024, that number had dropped to zero. Just 10 months after the program was canceled, newborn deaths began to climb again: one in December 2025, four more by March 2026.

    Many of these deaths will never be officially counted: the aid cuts also eliminated funding for mortality data collection, leaving vast stretches of rural Nepal without anyone to track and report preventable deaths. Campaign Nepal, a local partner of CARE, has documented eight infant deaths in Dewahi Gonahi since the cuts, but official government records list only two. “There must be more than that,” says Shatrudhan Singh, Campaign Nepal’s executive director. “We just can’t identify them.”

    Another young woman from the region, 19-year-old Phula Devi, shared her story of grief with the AP, one she had never told even her own husband. Uneducated and with no outreach worker to guide her, Phula did not understand the warning that her unborn baby had a slow heartbeat, and delayed going to the hospital at the direction of her relatives. When she arrived, doctors urged a C-section to deliver her overdue baby, but Phula did not understand the procedure and was terrified. She delivered the baby on her own, and he was stillborn. “I think of my baby all the time,” Phula says, hiding her tear-streaked face behind a scarf. “She would have done anything to save him, if she’d only known how.”

    For Kabita Mukhiya, the collapse of outreach services proved fatal. When she was pregnant with her third child, Yubraj, she received free nutritional supplements from the U.S.-funded program that helped offset her family’s meager diet, which provided barely enough to eat. By the time she became pregnant with her fourth child, the supplements were gone, along with the regular mother’s health meetings she had attended. She missed her first-trimester checkup entirely, and only showed up for her first screening at 16 weeks. Her nurse noticed she was dangerously pale and urged her to get a blood test to check for anemia, but Kabita did not understand why the test was necessary, and never got it. By the time she arrived at the hospital, her condition was irreversible.

    Rajkumari Patel, one of the community health volunteers who lost her job when the program was cut, says Kabita’s death is exactly what she was trained to prevent. “I used to know every pregnant woman in her village, visiting them at home,” Patel says. “I would have asked her, ‘Is the baby kicking? When did you last feel movement?’ I would have checked for swelling in her hands and face. I would have looked at her eyes for signs of anemia. These are the signs I would have noticed in Kabita and said, ‘This woman needs a hospital today — not tomorrow.’ Maybe we could have saved her life.”

    Nutrition data from the region confirms the widespread damage of cutting support programs. Before the U.S. cuts, the prevalence of life-threatening wasting (severe malnutrition) among children under five in Kabita’s province was 7.4%. A national screening conducted in May 2026 found that rate has jumped to 12.3% after the cuts eliminated most local nutrition support programs.

    In the months since Kabita’s death, her family has been left to pick up the pieces. Her husband, who was working construction in India when she died, arrived home three days after her funeral, and has been inconsolable, often refusing to work for days at a time. Kabita’s 60-something mother-in-law and aunt are now left to care for her three young children, ages 1, 3, and 5, with barely enough income to put rice on the table. “How will I feed them? I’m old,” says Lachhiya Devi, Kabita’s mother-in-law, as she strokes the leg of her sleeping 4-year-old granddaughter. “You can see how desperately I’m trying to get by.”

    Kabita’s aunt Shraddha, who carried her to the hospital and watched her take her final breath, says the tragedy could have been avoided entirely if outreach workers had still been in place to guide the village’s vulnerable women. “We don’t have anyone to help us out here, to tell us about these things. If there was someone, we would ask them, follow their advice,” she says. “It would have saved her life. She was too young to die.”

  • Ebola outbreak on track to be deadliest ever, WHO chief says

    Ebola outbreak on track to be deadliest ever, WHO chief says

    The world faces a rapidly escalating public health crisis in the eastern Democratic Republic of Congo (DRC), where the 2026 Ebola outbreak is projected to become the deadliest in recorded history if current infection trends hold, World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus has announced.

    Speaking to reporters, Tedros explained that at the current rate of transmission, the outbreak will eclipse the devastating 2014-2016 West African Ebola epidemic, which claimed more than 11,000 lives across the region. As of the latest WHO update, the 2026 outbreak – officially declared on May 15 – has already confirmed at least 4,300 cases and recorded over 2,000 deaths.

    While the WHO has set an ambitious goal to reverse the outbreak’s spread within a three-month window, agency officials have stressed that this target only refers to bringing community transmission under control, not eradicating the virus entirely. A key complicating factor that has fueled the outbreak’s rapid growth is its unrecognized early spread: health officials confirmed this week that the virus began circulating as early as February, three full months before the outbreak was formally declared. Early cases were misdiagnosed as more common local illnesses, including malaria and typhoid, allowing undetected transmission to continue for months.

    “We are chasing the virus, and the virus is ahead of us,” Dr Mohamed Janabi, WHO Regional Director for Africa, told reporters during a press briefing in Bunia, the DRC city closest to the outbreak’s epicenter.

    Compounding challenges for frontline response teams, the 2026 outbreak is caused by the rare Bundibugyo strain of Ebola, a variant that has only been linked to two small, previously documented outbreaks in 2007 and 2012. No vaccines or antiviral therapies have received full regulatory approval specifically for this strain, leaving response teams with no standard, proven tools to stop transmission or treat infected patients.

    Widespread regional instability in eastern DRC has further undermined containment efforts, Janabi added. Ongoing conflict has restricted access to affected communities, meaning health workers can only reach roughly 30% of confirmed cases to provide care and implement infection control measures.

    Ebola is an extremely virulent viral pathogen with a high mortality rate. Symptoms develop between 2 and 21 days after initial exposure, beginning with sudden flu-like manifestations including fever, headache and fatigue that easily mimic more common tropical illnesses like malaria. As infection progresses, patients develop severe vomiting and diarrhea, often leading to acute organ failure and death. The virus spreads between humans through direct contact with infected bodily fluids, such as blood or vomit.

    Despite the severe challenges, there are emerging signs of progress in research and development for targeted countermeasures. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted regulatory approval to launch the first human clinical trials for an investigational Bundibugyo Ebola vaccine. The candidate is being developed by a research team at the University of Oxford, built on the same stable mRNA-vectored platform that powered the Oxford-AstraZeneca COVID-19 vaccine. Three additional independent research groups are also working on alternative Bundibugyo vaccine candidates, though those are still in pre-clinical development and have not yet entered human testing.

    Separately, the WHO is sponsoring a clinical trial based in the DRC to test whether two existing antiviral therapies can improve survival rates for patients infected with the Bundibugyo strain, as global health authorities work to scale up evidence-based care while long-term vaccine development progresses.

  • WHO says Congo’s Ebola outbreak is on track to eclipse the deadliest one in history

    WHO says Congo’s Ebola outbreak is on track to eclipse the deadliest one in history

    GENEVA – The head of the World Health Organization issued a stark warning Wednesday that the ongoing Ebola outbreak in the Democratic Republic of the Congo is on course to become the deadliest Ebola epidemic on record, surpassing the 2014-2016 West African outbreak that claimed more than 11,000 lives across over 28,000 confirmed cases.

    Speaking to reporters gathered in Geneva, WHO Director-General Tedros Adhanom Ghebreyesus emphasized that based on the current rate of new infections and fatalities, the eastern Congo outbreak will soon overtake the historic 2014-2016 event as the worst Ebola outbreak the world has ever seen.

    Already, the outbreak – which public health officials classify as the fastest-growing in recorded history – has documented more than 4,300 confirmed cases and claimed more than 2,000 lives, according to WHO data. While the outbreak was not formally declared by Congolese health authorities until May 15, recent genetic sequencing analysis of virus samples has traced the first infections back to February, meaning the outbreak has been spreading undetected in local communities for months before an official response was launched.

    What makes this outbreak particularly challenging for frontline health workers is the unique strain of virus driving it: the rare Bundibugyo Ebola variant, for which no licensed vaccines or targeted antiviral treatments currently exist. This leaves medical teams limited in their ability to protect at-risk populations and improve outcomes for infected patients.

    Compounding these challenges is the geographic and security context of the outbreak. The virus is spreading across remote, conflict-ravaged regions of eastern Congo, close to the country’s shared borders with South Sudan, Uganda, and Rwanda – a location that raises the risk of cross-border transmission to neighboring countries. Epidemiologists tracking the outbreak note that the virus is spreading more quickly than response teams can scale up their monitoring and containment efforts. A majority of new cases and deaths continue to occur in local communities that remain inaccessible to health workers, allowing the virus to spread undetected and unchallenged.